Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBX2 antisense RNA 1 (TBX2-AS1, LOC101927855) is a long non-coding RNA transcribed in the opposite direction from the TBX2 gene locus. It is tightly co-expressed with TBX2 and is thought to regulate TBX2 in cis, with its expression increasing in response to TBX2 or MYCN knockdown, possibly as a part of a compensatory mechanism. TBX2-AS1's detailed biological and pathological roles remain unclear, but its co-expression with TBX2—a transcription factor implicated in cell cycle progression and cancer—suggests it may participate in complex gene regulatory networks relevant to disease, particularly malignancy[2]. There are currently no drugs, direct mechanisms of action, or established safety concerns known for TBX2-AS1. Its utility as a biomarker or therapeutic target is unproven but could be explored in cancer contexts where TBX2 function is relevant[2].
None established for drugs targeting TBX2-AS1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBX2 antisense RNA 1 (TBX2-AS1).